Through its publications, INSS aims to provide expert insights, cutting-edge research, and innovative solutions that contribute to shaping the national security discourse and preparing the next generation of leaders in the field.
Sept. 1, 2012
The Presidential Nuclear Initiatives of 1991-1992
On the morning of September 28, 1991, then-Colonel Frank Klotz witnessed an historic moment at Grand Forks Air Force Base, North Dakota. As he and other senior officers from the base bomber and missile units watched, the crews for the B-1 strategic bombers that had been on alert that day climbed into their cockpits, started the planes, and taxied one after another away from the alert aircraft parking area. That scene was repeated at all 11 Strategic Air Command (SAC) bases in the United States. By the end of the day, there were no U.S. bombers on alert for the first time in over 30 years.
Jan. 1, 2010
U.S. Withdrawal from the Antiballistic Missile Treaty
As President George W. Bush made these remarks in a speech at the National Defense University (NDU) on May 1, 2001, National Security Council (NSC) Senior Director for Proliferation Strategy, Counterproliferation, and Homeland Defense Robert Joseph listened attentively. Within just 4 months of taking office, President Bush was articulating one of his key national security priorities: setting the conditions for the United States to move full steam ahead on developing, testing, and eventually deploying a wide range of missile defense technologies and systems—a priority that in all likelihood would mean U.S. withdrawal from the 1972 Antiballistic Missile (ABM) Treaty.
Oct. 1, 2009
President Nixon’s Decision to Renounce the U.S. Offensive Biological Weapons Program
The nuclear arms race between the United States and the Soviet Union was a prominent feature of the Cold War. A lesser known but equally dangerous element of the superpower competition involved biological weapons (BW), living microorganisms that cause fatal or incapacitating diseases in humans, animals, or plants. By the late 1960s, the United States and the Soviet Union had both acquired advanced BW capabilities. The U.S. biological weapons complex, operated by the U.S. Army Chemical Corps, consisted of a research and development laboratory at Fort Detrick in Maryland, an open-air testing site at Dugway Proving Ground in Utah, and a production facility at Pine Bluff Arsenal in Arkansas that manufactured biological warfare agents and loaded them into bomblets, bombs, and spray tanks.